Individualized homeopathy in a group of Egyptian asthmatic children

Heba Farid Shafei; Soha Mahmoud AbdelDayem; Nagwa Hassan Mohamed

doi:10.1016/j.homp.2012.08.006

Homeopathy, Table of Contents

Homeopathy 2012; 101(04): 224-230
DOI: 10.1016/j.homp.2012.08.006

Original Paper

Individualized homeopathy in a group of Egyptian asthmatic children

Authors

Heba Farid Shafei

¹Complementary and Alternative Medicine Department, Medical Research Division, National Research Center, Cairo, Egypt
Soha Mahmoud AbdelDayem

²Pediatrics Department, Medical Research Division, National Research Center, Cairo, Egypt
Nagwa Hassan Mohamed

¹Complementary and Alternative Medicine Department, Medical Research Division, National Research Center, Cairo, Egypt

Subject Editor:

Abstract

Objectives: To evaluate homeopathy as an adjunctive treatment for bronchial asthma in children.

Methods: In a prospective observational longitudinal study the effects of individualised homeopathic medicines were assessed in 30 children with asthma as an adjunct to conventional treatment. The main outcome measures were frequency of attacks, use of medication, night awakening and spirometry at baseline and at follow-up till 6 months.

Results: There were clinically relevant and statistically significant changes in those measuring severity, indicating relative improvements after 3 months and absolute improvements after 6 months of treatment by homeopathic medicines.

Conclusions: This study provides evidence that homeopathic medicines, as prescribed by experienced homeopathic practitioners, improve severity of asthma in children. Controlled studies should be conducted.

Keywords

Homeopathy - Childhood bronchial asthma - Homeopathic medicines - Spirometry - Simillimum - Observational study

Full Text

References

References
1 Lewith G.T., Watkins A.D., Hyland M.E., Broomfield J.A., Dolan G., Holgate S.T. Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial. BMJ 2002; 324: 1-5.
2 Zedan M., Settin A., Farag M., Ezz-Elregal M., Osman E., Fouda A. Prevalence of bronchial asthma among Egyptian school children. Egypt J Bronchol 2009; 3 (02) 124-130.
3 WHO. Asthma. Fact sheet N°307, 2011.
4 Expert Panel Report 3. Guidelines for the diagnosis and management of asthma. National asthma education and prevention program. National Heart, Lung and Blood Institute. National Institutes of Health; 2007. Full Report.
5 Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI). Global strategy for asthma management and prevention. Bethesda (MD): Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI); 2006.
6 Garcia M.L., Wahn U., Gilles L., Swern A., Tozzi C.A., Polos P. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 2005; 116 (No. 2): 360-369.
7 Sezfler S.J., Martin R.J. Lessons learned from variation in response to therapy in clinical trials. J Allergy Clin Immunol 2010; 125: 285-292.
8 Sezfler S.J. Advances in pediatric asthma in 2010: addressing the major issues. J Allergy Clin Immunol 2011; 127 (01) 102-115.
9 El-Sayed Z.A., Hamza R.T., Sayed N.A., Mahmoud N.H. Effect of inhaled corticosteroids on growth and puberty in Egyptian asthmatic children & adolescents. Pak J Biol Sci 2010; 13 (20) 977-984.
10 Kurt E., Barbek S., Pasaoglu G., Abadoglu O., Misirligil Z. Use of alternative medicine by allergic patient Turker. Allergol Immunpathol (Mads) 2004; 32 (05) 289-294.
11 WHO traditional medicine strategy 2002–2005. Geneva: World Health Organization; 2002.
12 Safety issues in the preparation of homeopathic medicines. World Health Organization; 2010.
13 Ernst E. Use of complementary therapies in childhood asthma. Pediatr Asthma Allergy Immunol 1998; 12: 29-32.
14 Letts M. The jury's out. National Asthma Campaign report. London: National Asthma Campaign; 1998.
15 Eizayaga F.X., Eizayage J., Eizayaga F. Homoeopathic treatment of bronchial asthma. Br Homeopath J 1996; 85: 2833.
16 Nolleveaux M.A. Interet de la prescription d'APP (Apis 15 cH, PulmoHistaminum 15 cH, Pollantinum 30 cH) dans la rhinite allergique. Observations cliniques en pratique journaliere. Homeopathie Francaise 1992; 80: 2433.
17 Dutartre D. Etude comparative entre desensibilisation classique et desensibilisation homeopathique. A propos de cas cliniques. Act Homeopathique 1990; 1: 214.
18 In: Watt J., Wood C. Talking Health: Conventional and Complementary Approaches. 1988. London: Royal Society of Medicine.;
19 British Medical Association. Complementary medicine: new approaches to good practice. Oxford: Oxford University Press; 1993.
20 Office of Technology Assessment. Unconventional cancer treatments. Washington DC: Government Printing Office; 1990. (OTAH405).
21 House of Lords Select Committee on Science and Technology. Complementary and alternative medicine. 6th Report. London: Science and Technology Committee Publications; 2000.
22 NHLBI/WHO. Global initiative for asthma: global strategy for asthma management and prevention. Bethesda, MD: National Institutes of Health/National Heart, Lung, and Blood Institute; 1996. (Publication number 953659).
23 Linde K., Clausius N., Ramirez G. et al. Are the clinical effects of homoeopathy placebo effects? A metaanalysis of placebocontrolled trials. Lancet 1997; 350: 834-843.
24 Bellavite P., Ortolani R., Pontarollo F., Piasere V., Benato G., Conforti A. Immunology and homeopathy. 4. Clinical studies—Part 2. eCAM 2006; 3 (04) 397-409.
25 Juniper E.F., O'Byrne P.M., Guyatt G.H., Ferrie P.J., King D.R. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14 (04) 902-907.
26 Greenough A., Stocks J., Nothen U., Helms P. Total respiratory compliance and functional residual capacity in young children. Pediatr Pulmonol 1986; 2 (06) 321-326.
27 Colin P. Homeopathy and respiratory allergies: a series of 147 cases. Homeopathy 2006; 95: 68-72.
28 Rossi E., Endrizzi C., Panazzo M.A., Bianchi A., Da Fre. Homeopathy in the public health system: a seven year observational study at Lucca hospital (Italy). Homeopathy 2009; 98: 142-148.
29 LaForce C.F., Pearlman D.S., Ruff M.E. et al. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma. Ann Allergy Asthma Immunol 2000; 85: 407-415.
30 Katz Y., Lebas F.X., Medley H.V., Robson R. Fluticasone propionate 50 μg BID versus 100 μg BID in the treatment of children with persistent asthma. Clin Ther 1998; 20: 424-437.
31 Purucker M.E., Rosebraugh C.J., Zhou F., Meyer R.J. Inhaled fluticasone propionate by discus in the treatment of asthma. Chest 2003; 124: 1584-1593.
32 Wassenhoven van M., Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy 2004; 93: 3-11.
33 Robinson T. Responses to homeopathic treatment in National Health Service general practice. Homeopathy 2006; 95: 9-14.
34 Spence D.S., Thompson E., Barron S.J. Homeopathic treatment for chronic disease: a 6 year University Hospital outpatients observational study. J Altern Complement Med 2005: 793-798.
35 Eizeyaga J.E., Eizeyaga J.I. Prospective observational study of 42 patients with atopic dermatitis treated with homeopathic medicines. Homeopathy 2012; 101: 21-27.
36 Witt C., Lüdtke R., Mengler N., Willich S. How healthy are chronically ill patients after eight years of homeopathic treatment? – results from a long term observational study. BMC Public Health 2008; 8: 413 10.1186/1471-2458-8-413.
37 Endrizzi C., Rossi E. Patient compliance with homeopathic therapy. Homeopathy 2006; 95: 206-214.
38 White A., Slade P., Hunt C., Hart A., Ernst E. Individualised homeopathy as an adjunct in the treatment of childhood asthma: a randomised placebo controlled trial. Thorax 2003; 58: 317-321.